Paul Thompson

Founder at Padlock Therapeutics, Inc.

Consumer Services

Health Technology

Profile

Paul Thompson is the founder of Padlock Therapeutics, Inc. He is currently working as a Professor & Director-Chemical Biology at the University of Massachusetts Medical School.
He completed his undergraduate and doctorate degrees from McMaster University.

Paul Thompson active positions

Companies	Position	Start
Padlock Therapeutics, Inc. Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA.	Founder	-
UMass Chan Medical School	Corporate Officer/Principal	-

All active positions of Paul Thompson

Training of Paul Thompson

McMaster University

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul Thompson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Padlock Therapeutics, Inc. Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA.	Health Technology